Orexin-A (Hypocretin-1) and leptin enhance UP in the dentate gyrus of rats in vivo

被引:150
作者
Wayner, MJ
Armstrong, DL
Phelix, CF
Oomura, Y
机构
[1] Univ Texas, Dept Biol, San Antonio, TX 78249 USA
[2] Kyushu Univ, Grad Sch Med Sci, Dept Integrat Physiol, Fukuoka 8120054, Japan
关键词
orexin-A; LTP; dentate granule cells; perforant path afferents; hippocarnpus orexin 1 receptor; SB-334867; leptin; schaffer collaterals; CA1;
D O I
10.1016/j.peptides.2004.03.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Orexin-A (Hypocretin-1) has been localized in the posterior and lateral hypothalamic perifornical region. Orexin containing axon terminals have been found in hypothalamic nuclei and many other parts of the brain; for example, the hippocampus. Two types of orexin receptors have been discovered. Orexin I type of receptors have been described and been shown to be widely distributed in the rat brain including the hippocampus. Subsequently Orexin-A was found to impair both water maze performance and hippocampal long term potentiation (LTP). Leptin is expressed in adipose tissue and released into the blood where it affects food intake and can also produce widespread physiological changes mediated via autonomic preganglionic neurons, pituitary gland, and cerebral cortex. Immunoreactivity for leptin receptors has been found in various hypothalamic nuclei including the lateral hypothalamic area as well as the hippocampus especially in the dentate gyrus and CA1. Leptin receptor deficient rats and mice also show impaired UP in CA1 and poor performance in the water maze. The present study was conducted to determine the effects of 0.0, 30, 60, 90, and 100 nM, orexin-A, and leptin, 0.0, 1.0, 100 nM, 1, and 10 muM, ha 1.0 mul of ACSF, applied directly into the dentate gyrus, on UP in medial perforant path dentate granule cell synapses in urethane anesthetized rats. Orexin-A specifically enhanced UP at the 90 nM dose; and it was possible to block the enhancement by pretreating the animals with SB-334867, a specific orexin 1 receptor antagonist. Leptin enhanced normal UP at 1.0 muM but inhibited UP at lower and higher doses. These results and previous data indicate that the same peptide could possibly have different modulatory post synaptic effects in different hippocampal synapses dependent upon different types of post synaptic receptors. (C) 2004 Elsevier Inc. All Rights reserved.
引用
收藏
页码:991 / 996
页数:6
相关论文
共 33 条
[1]   Orexin-A (hypocretin-1) impairs Morris water maze performance and CA1-schaffer collateral long-term potentiation in rats [J].
Aou, S ;
Li, XL ;
Li, AJ ;
Oomura, Y ;
Shiraishi, T ;
Sasaki, K ;
Imamura, T ;
Wayner, MJ .
NEUROSCIENCE, 2003, 119 (04) :1221-1228
[2]  
CHERNELLI RM, 1999, CELL, V98, P437
[3]   Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems [J].
Date, Y ;
Ueta, Y ;
Yamashita, H ;
Yamaguchi, H ;
Matsukura, S ;
Kangawa, K ;
Sakurai, T ;
Yanagisawa, M ;
Nakazato, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :748-753
[4]   The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity [J].
De Lecea, L ;
Kilduff, TS ;
Peyron, C ;
Gao, XB ;
Foye, PE ;
Danielson, PE ;
Fukuhara, C ;
Battenberg, ELF ;
Gautvik, VT ;
Bartlett, FS ;
Frankel, WN ;
van den Pol, AN ;
Bloom, FE ;
Gautvik, KM ;
Sutcliffe, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :322-327
[5]   Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action [J].
Dube, MG ;
Kalra, SP ;
Kalra, PS .
BRAIN RESEARCH, 1999, 842 (02) :473-477
[6]   Unraveling the central nervous system pathways underlying responses to leptin [J].
Elmquist, JK ;
Maratos-Flier, E ;
Saper, CB ;
Flier, JS .
NATURE NEUROSCIENCE, 1998, 1 (06) :445-450
[7]   Effects of recombinant leptin therapy in a child with congenital leptin deficiency [J].
Farooqi, IS ;
Jebb, SA ;
Langmack, G ;
Lawrence, E ;
Cheetham, CH ;
Prentice, AM ;
Hughes, IA ;
McCamish, MA ;
O'Rahilly, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (12) :879-884
[8]  
Håkansson ML, 1998, J NEUROSCI, V18, P559
[9]   Recombinant leptin for weight loss in obese and lean adults - A randomized, controlled, dose-escalation trial [J].
Heymsfield, SB ;
Greenberg, AS ;
Fujioka, K ;
Dixon, RM ;
Kushner, R ;
Hunt, T ;
Lubina, JA ;
Patane, J ;
Self, B ;
Hunt, P ;
McCamish, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1568-1575
[10]   Localization of leptin receptor mRNA expression in mouse brain [J].
Huang, XF ;
Koutcherov, I ;
Lin, S ;
Wang, HQ ;
Storlien, L .
NEUROREPORT, 1996, 7 (15-17) :2635-2638